Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 4Unknown 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 34Breast 19CNS 11Genitourinary 8Thoracic 7Dermatologic 6Gynecologic 5Head & Neck 4Sarcoma 3Other solid neoplasm 2

Conditions

Retinoblastoma 1Mesothelioma, Malignant 1

Interventions

Injections 17Cisplatin 15Carboplatin 15Oxaliplatin 11Gemcitabine 11pembrolizumab 8Capecitabine 8toripalimab 7Paclitaxel 7Etoposide 7Cyclophosphamide 7Pemetrexed 6Irinotecan 6Drug Therapy 6spartalizumab 5fludarabine 5camrelizumab 5Vincristine 5Radiotherapy 5Leucovorin 5tislelizumab 4apatinib 4anlotinib 4Interleukin-2 4Immune Checkpoint Inhibitors 4Granulocyte-Macrophage Colony-Stimulating Factor 4Fluorouracil 4Docetaxel 4Bevacizumab 4tremelimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Chemotherapy, Adjuvant × Other solid neoplasm × Clear all
NCT00360750 2013-09-17

Chemotherapy With or Without Radiation Therapy or Observation in Treating Young Patients With Advanced Retinoblastoma Who Have Undergone Surgery to Remove the Eye

National Cancer Institute (NCI)

Phase NA Unknown
Other solid neoplasm

Retinoblastoma

NCT00253409 2009-07-14

Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery

National Cancer Institute (NCI)

Phase NA Unknown
670 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡